eculizumab
Commercial- Indications
- Rare diseases
Company intelligence / Profile preview
Nufactor is an accredited specialty infusion pharmacy providing home infusion therapies for chronic conditions. It dispenses FDA-approved biologics such as immunoglobulins, antihemophilic factors, infliximab, golimumab, and is the exclusive specialty pharmacy for YCANTH™, the first FDA-approved treatment for molluscum contagiosum. The company has received URAC's Specialty Pharmacy Accreditation and The Joint Commission's Gold Seal of Approval®.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nufactor.